Previous Close | 164.97 |
Open | 164.92 |
Bid | 165.99 x 1000 |
Ask | 166.27 x 900 |
Day's Range | 164.68 - 166.46 |
52 Week Range | 114.69 - 167.75 |
Volume | |
Avg. Volume | 1,318,011 |
Market Cap | 20.595B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | 74.23 |
EPS (TTM) | 2.24 |
Earnings Date | Oct 30, 2024 - Nov 04, 2024 |
Forward Dividend & Yield | 4.88 (2.93%) |
Ex-Dividend Date | Aug 14, 2024 |
1y Target Est | 149.91 |
CLX looks poised for growth through recent recovery, improved distribution channels, and focus on innovation and expansion, amid inflation and cost headwinds.
Clorox completes the divestiture of its Better Health VMS business. The company's IGNITE strategy also bodes well.
The Clorox Company (NYSE: CLX) today announced the completion of the previously disclosed divestiture of its Better Health Vitamins, Minerals and Supplements (VMS) business in its entirety to an affiliate of Piping Rock Health Products, LLC. The divested business includes the Natural Vitality, NeoCell, Rainbow Light and RenewLife brands, relevant trademarks and licenses, and associated manufacturing and distribution facilities in Sunrise, Florida.